Enzo Biochem (NYSE:ENZ) Now Covered by StockNews.com

Investment analysts at StockNews.com began coverage on shares of Enzo Biochem (NYSE:ENZGet Free Report) in a report issued on Friday. The brokerage set a “hold” rating on the medical research company’s stock.

Enzo Biochem Price Performance

Shares of Enzo Biochem stock opened at $1.04 on Friday. The company’s fifty day simple moving average is $1.13 and its two-hundred day simple moving average is $1.12. Enzo Biochem has a 12-month low of $0.99 and a 12-month high of $1.50.

Hedge Funds Weigh In On Enzo Biochem

Several institutional investors have recently made changes to their positions in ENZ. Renaissance Technologies LLC grew its holdings in Enzo Biochem by 2.6% during the 2nd quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock valued at $2,725,000 after buying an additional 64,417 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Enzo Biochem by 3.3% in the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after buying an additional 11,742 shares in the last quarter. BBR Partners LLC purchased a new position in shares of Enzo Biochem in the 3rd quarter worth approximately $112,000. Finally, XTX Topco Ltd raised its stake in shares of Enzo Biochem by 94.5% in the second quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock valued at $31,000 after acquiring an additional 13,735 shares during the period. Institutional investors own 36.90% of the company’s stock.

About Enzo Biochem

(Get Free Report)

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.

Featured Articles

Receive News & Ratings for Enzo Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzo Biochem and related companies with MarketBeat.com's FREE daily email newsletter.